drugset / Trial / NCT03011970

Temporal Dynamics and Pharmacokinetics of Intranasally Administered Oxytocin

NCT03011970

Phase 1 Completed 116 enrolled University Hospital, Bonn
RandomizedCrossoverTriple-blindBasic science

Summary

The purpose of this study is to determine whether effects of intranasal oxytocin on amygdala response vary as a function of treatment dose and dose-test latency.

Timeline

Start
2014-09
Primary completion
2015-12
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxytocin Peptide 12 iu Intranasal
Comparator Oxytocin Peptide 24 iu Intranasal
Comparator Oxytocin Peptide 48 iu Intranasal

Indications

No indication recorded.